Newswise — Researchers at Penn State College of Medicine and Cold Spring Harbor Laboratory have reported the first-ever quantitative whole-brain map of inhibitory neurons in the mouse brain. These brain cells play a crucial role in regulating response to stimuli and have been widely implicated in many psychiatric conditions.
The researchers found surprising differences in the number of inhibitory neurons in different areas of the brain and in the brains of female and male mice.
Neurons operating within the central nervous system can be roughly divided into two major cell types: excitatory and inhibitory neurons. Excitatory neurons are the main carriers of information, much like an accelerator in a car, while inhibitory neurons control the activity of excitatory neurons—like the car's brake.
Processing external stimuli and generating appropriate behavioral responses requires a fine balance between these excitatory and inhibitory neurons. Inhibitory neurons are particularly critical for proper brain processing. For example, impairment of these brain cells has been linked to brain disorders including autism and schizophrenia.
The density of inhibitory neurons in a brain region dictates their strength of inhibition. Until recently, scientists have assumed that different inhibitory neurons, which have different functions, are evenly distributed in the brain. But the new study turned up a surprise.
Yongsoo Kim, assistant professor in the Department of Neural and Behavioral Sciences at Penn State College of Medicine, used a new imaging and data analysis method he co-developed in Pavel Osten’s lab at CSHL called the quantitative whole-brain (qBrain) platform to count and map three mainly inhibitory neuronal types and four of their sub-types in intact mouse brains.
He found different amounts of two main inhibitory neurons, parvalbumin positive (PV+) and somatostatin positive (SST+) neurons, in the medial prefrontal cortex, an area that's involved with executive functions like planning and decision-making. In contrast, sensory brain regions had a more equal distribution of these neurons.
SST+ neurons modulate input of sensory information to excitatory neurons. PV+ neurons, on the other hand, are like a final brake, controlling output from excitatory neurons. In Kim's study, SST+ neurons far outnumbered the PV+ type in higher order cortical areas.
The research was published this week in the journal Cell.
"This provides new anatomical evidence to explain how high cognitive brain regions can basically compute all the information that's coming from the sensory brain regions and make sense out of the external world," Kim said.
Kim also found differences between male and female mice in brain regions implicated in sexual dimorphisms. Despite males having larger brains by volume on average, females had greater numbers of inhibitory neurons throughout these regions. The only exception: Males had three-times more SST+ interneurons in a brain region linked with ejaculation, possibly helping to finely control related function.
The study is proof of concept that specific brain cells can now be imaged and quantified with cellular resolution in intact brains, allowing for the first cell-specific 3D brain maps.
In the future, this advance could allow scientists to study brain disorders in humans in a way that's never been possible before. By comparing cell counts and locations in healthy and disordered brains, researchers may be able to pinpoint cell-specific disruption in psychiatric disease, target new therapeutics and measure if treatments are working.
For now, the qBrain resource, which includes tables with cell counts and cell densities for over 800 anatomical regions delineated by the Allen Mouse Brain Atlas, graphic visualizations of the data in 3D movies, 2D flatmaps and serial section datasets are openly available at the group's webportal mouse.brainarchitecture.org/cellcounts/ost.
In addition to Kim, first author; and Osten, senior author, other scientists on the project were Guangyu Robert Yang at New York University (NYU); Kith Pradhan, Kannan Umadevi Venkataraju, Greg Fitzgerald, Mihail Bota, Partha Mitra and Z. Josh Huang, all at CSHL; Luis Carlos García del Molino at NYU; Keerthi Ram, IIT Madras, Chennai, India; Miao He, Fudan University, Shanghai, China; Jesse Maurica Levine, all at CSHL and Stony Brook University; and Xiao-Jing Wang, at NYU and NYU Shanghai, Shanghai, China.
This work was supported by NIH grants U01MH105971 (P.O.) and R01MH062349 (X.J.W.), Simons Foundation Autism Research Initiative (P.O. and P. M.), STCSM grants 14JC1404900 and 15JC1400104 (X.J.W), the Pennsylvania Department of Health Tobacco CURE Funds SAP#4100062216 (Y.K.), Samuel J. and Joan B. Williamson Fellowship (G.R.Y.), Mathers Charitable Foundation H N Mahabala Chair Professorship (P.M.), and IIT Madras (K.R. and P.M).
About Penn State College of Medicine
Located on the campus of Penn State Health Milton S. Hershey Medical Center in Hershey, Pa., Penn State College of Medicine boasts a portfolio of nearly $110 million in funded research. Projects range from the development of artificial organs and advanced diagnostics to groundbreaking cancer treatments and understanding the fundamental causes of disease. Enrolling its first students in 1967, the College of Medicine has more than 1,700 students and trainees in medicine, nursing, the health professions and biomedical research on its Hershey campus and a regional campus in State College, Pa.